Abstract: Described are methods for preparing salts of 5-nitrotetrazolate by reacting 5-aminotetrazole, an acid, and sodium nitrite in water in a batch reaction at an elevated temperature. As examples, the acid is nitric acid, sulfuric acid, perchloric acid, or hydrochloric acid, and the elevated temperature is at or above 65° C.

Abstract: Disclosed herein are methods, systems, and articles associated with correlating detected changes within a computer network with remediation processes performed in response to policy test failures. In embodiments, on determination that a failure of a policy test has occurred within a computer network having a number of nodes, a remediation process may be executed to remediate the failure. Change at a node may be detected. Further, the detected change may be correlated with the execution of the remediation process, and the correlation may be identified.

Abstract: Disclosed herein are methods, systems, and articles associated with remediation execution. In embodiments, a set of policy test failures may be selected for remediation. The set of policy test failures may be associated with a computer network with a number of nodes. For each failure within the set of policy test failures, a remediation script may be obtained to remediate a corresponding policy test failure. The remediation scripts may be selectively provided to nodes that are affected by policy test failures, for execution by the nodes. A remediation script result for each remediation script executed may be received. Based upon the remediation script results, it may be determined whether or not execution of the remediation scripts was successful.

Abstract: Disclosed herein are methods, systems, and articles associated with remediation workflow. A method may include determining one or more test failures related to a policy test within a computer network, and reviewing the one or more test failures. The method may further include, based upon a result of the reviewing, creating a remediation work order that includes at least one of the one or more test failures. Each test failure within the remediation work order may be approved or denied. For each test failure that is approved for remediation, a remediation process may be executed.

Abstract: A plinth constructed of plastics material including a platform; a continuous side wall depending from said platform and adapted to rest on the ground, said side wall including one or more peripheral portions and one or more divider portions, each of said one or more divider portions dividing the platform into at least two load bearing sections and each divider portion including two spaced apart divider wall portions joined by a bottom wall adapted to rest on the ground so as to support the adjacent load bearing sections of said platform, said platform, said divider wall portions and said bottom wall providing a continuous top face.

Abstract: Disclosed herein are methods, systems, and articles associated with correlating detected changes within a computer network with remediation processes performed in response to policy test failures. In embodiments, on determination that a failure of a policy test has occurred within a computer network having a number of nodes, a remediation process may be executed to remediate the failure. Change at a node may be detected. Further, the detected change may be correlated with the execution of the remediation process, and the correlation may be identified.

Abstract: Disclosed herein are methods, systems, and articles associated with remediation execution. In embodiments, a set of policy test failures may be selected for remediation. The set of policy test failures may be associated with a computer network with a number of nodes. For each failure within the set of policy test failures, a remediation script may be obtained to remediate a corresponding policy test failure. The remediation scripts may be selectively provided to nodes that are affected by policy test failures, for execution by the nodes. A remediation script result for each remediation script executed may be received. Based upon the remediation script results, it may be determined whether or not execution of the remediation scripts was successful.

Abstract: Disclosed herein are methods, systems, and articles associated with remediation workflow. A method may include determining one or more test failures related to a policy test within a computer network, and reviewing the one or more test failures. The method may further include, based upon a result of the reviewing, creating a remediation work order that includes at least one of the one or more test failures. Each test failure within the remediation work order may be approved or denied. For each test failure that is approved for remediation, a remediation process may be executed.

Abstract: Disclosed herein are methods, systems, and articles for promoting changes that result from remediation performed within a computer network, for compliance review. Policy tests may be provided within the computer network, which comprises a number of nodes. The policy tests may relate to configuration parameters and compliance requirements for various nodes within the computer network. At least one pattern relating to nodes within the computer network that may be affected by execution of a remediation script is determined. Nodes within the computer network may be identified, based at least in part on the at least one pattern. Subsequent to execution of the remediation script, a list of nodes whose state has changed may be promoted for compliance review.

Abstract: A plinth constructed of plastics material including a platform; a continuous side wall depending from said platform and adapted to rest on the ground, said side wall including one or more peripheral portions and one or more divider portions, each of said one or more divider portions dividing the platform into at least two load bearing sections and each divider portion including two spaced apart divider wall portions joined by a bottom wall adapted to rest on the ground so as to support the adjacent load bearing sections of said platform, said platform, said divider wall portions and said bottom wall providing a continuous top face.

Abstract: A plinth constructed of plastics material including a platform; a continuous side wall depending from said platform and adapted to rest on the ground, said side wall including one or more peripheral portions and one or more divider portions, each of said one or more divider portions dividing the platform into at least two load bearing sections and each divider portion including two spaced apart divider wall portions joined by a bottom wall adapted to rest on the ground so as to support the adjacent load bearing sections of said platform, said platform, said divider wall portions and said bottom wall providing a continuous top face.

Abstract: Novel compounds are provided in the form of a salt having the structure of formula (I) or formula (II) wherein: R1 is selected from the group consisting of H, C1-C24 alkyl, C2-C24 alkenyl, C2-C24 alkynyl, C5-C20 aryl, C6-C24 alkaryl, and C6-C24 aralkyl; R2 is H, C1-C24 alkyl or nitro; X is O or NR3 in which R3 is H, C1-C24 alkyl or nitro; Zm+ is a monovalent cation, a divalent cation, or a trivalent cation; M+ is an alkali metal cation; and m and n are 1, 2 or 3, with the proviso that the compound contains at least one nitro group. Exemplary such compounds are the ammonium salt of the N-hydroxyl-N?-nitrourea (NHNU) monoanion and the disodium salt of the NHNU dianion. Also provided, as novel compositions of matter, are N-hydroxyl-N?-nitrourea and N-hydroxyl-N-nitroguanidine in electronically neutral form. The compounds are useful in a variety of contexts, but are primarily useful as high energy oxidizing agents in explosive compositions, propellant formulations, gas-generating compositions, and the like.

Abstract: A method is provided for enhancing the solubility of an ionizable compound in a lipophilic medium by admixing the compound with an effective solubility-enhancing amount of an N,N-dinitramide salt. The ionizable compound, upon ionization, gives rise to a biologically active cationic species that ionically associates with the N,N-dinitramide anion N(NO2)2− following admixture with the N,N-dinitramide salt. The biologically active cationic species may be a pharmacologically active cation, in which case the method is useful for enhancing the penetration of the blood-brain barrier by the pharmacologically active cation. In other embodiments, the ionizable compounds are medical imaging or diagnostic agents, or agricultural agents such as pesticides. Salts of biologically active cations and N,N-dinitramide ion are also provided as novel compositions of matter.

Abstract: The present invention features methods for preparing stabilized &agr;-AlH3 and &agr;′-AlH3, compositions containing these alane polymorphs, e.g., energetic compositions such as rocket propellants, and methods for using the novel polymorphs as chemical reducing agents, polymerization catalysts, and as a hydrogen source in fuel cells and batteries. The method produces stabilized alane by treating &agr;-AlH3 with an acidic solution that optionally contains a stabilizing agent such as an electron donor, an electron acceptor, or a compound which coordinates the Al3+ ion.

Abstract: Novel compounds are provided in the form of nucleoside pyrophosphate and triphosphate analogs. In these analogs, the pyrophosphate or triphosphate group is replaced with a moiety that is isosterically and electronically identical thereto, but is hydrolytically and enzymatically more stable. The compounds are useful as therapeutic agents, e.g., as antiviral agents, anticancer agents, metabolic moderators and the like. The invention also provides pharmaceutical compositions containing a compound of the invention as an active agent, and in addition provides methods of treating disease, including viral infections, cancer, bacterial infections, inflammatory and/or autoimmune diseases, and the like, by administering a compound of the invention to a patient in need of such treatment.

Abstract: Novel compounds are provided having the structural formula R[—N(NO2)—L—R1]n wherein R, L, R1 and n are defined herein. The compounds are useful in a variety of contexts, but are primarily to be used as high energy oxidizing agents in explosive compositions, propellant formulations, gas-generating compositions and the like. The compounds are also useful as pharmaceutical agents. Compositions containing the compounds are also provided, including energetic compositions, as are methods for using the novel compounds and compositions.

Abstract: A method is provided for enhancing the solubility of an ionizable compound in a lipophilic medium by admixing the compound with an effective solubility-enhancing amount of an N,N-dinitramide salt. The ionizable compound, upon ionization, gives rise to a biologically active cationic species that ionically associates with the N,N-dinitramide anion N(NO2)2− following admixture with the N,N-dinitramide salt. The biologically active cationic species may be a pharmacologically active cation, in which case the method is useful for enhancing the penetration of the blood-brain barrier by the pharmacologically active cation. In other embodiments, the ionizable compounds are medical imaging or diagnostic agents, or agricultural agents such as pesticides. Salts of biologically active cations and N,N-dinitramide ion are also provided as novel compositions of matter.

Abstract: Novel compounds are provided having the structural formula R[—N(NO2)—L—R1]n wherein R, L, R1 and n are defined herein. The compounds are useful in a variety of contexts, but are primarily to be used as high energy oxidizing agents in explosive compositions, propellant formulations, gas-generating compositions and the like. The compounds are also useful as pharmaceutical agents. Compositions containing the compounds are also provided, including energetic compositions, as are methods for using the novel compounds and compositions.

Abstract: The present invention features methods for preparing stabilized &agr;-AlH3 and &agr;′-AlH3, compositions containing these alane polymorphs, e.g., energetic compositions such as rocket propellants, and methods for using the novel polymorphs as chemical reducing agents, polymerization catalysts, and as a hydrogen source in fuel cells and batteries. The method produces stabilized alane by treating &agr;-AlH3 with an acidic solution that optionally contains a stabilizing agent such as an electron donor, an electron acceptor, or a compound which coordinates the Al3+ ion.

Abstract: Novel compounds are provided in the form of nucleoside pyrophosphate and triphosphate analogs. In these analogs, the pyrophosphate or triphosphate group is replaced with a moiety that is isosterically and electronically identical thereto, but is hydrolytically and enzymatically more stable. The compounds are useful as therapeutic agents, e.g., as antiviral agents, anticancer agents, metabolic moderators and the like. The invention also provides pharmaceutical compositions containing a compound of the invention as an active agent, and in addition provides methods of treating disease, including viral infections, cancer, bacterial infections, inflammatory and/or autoimmune diseases, and the like, by administering a compound of the invention to a patient in need of such treatment.